- Details
Aerie Pharmaceuticals announced positive 12-month interim safety results for Rhopressa, a once-daily eye drop for patients with glaucoma or ocular hypertension.
- Details
The ArcScan Insight 100 can image and measure anterior chamber depth, angle-to-angle width, individual corneal layers and sulcus-to-sulcus width, all with micron level precision.
- Details
Six-month results from this phase 2 randomized study shows that the anti-seizure drug phenytoin protects against retinal nerve fiber layer loss in acute optic neuritis.
Read more: Anti-seizure drug appears neuroprotective in acute optic neuritis
- Details
This retrospective study shows that illuminated microcatheter-assisted trabeculotomy can treat childhood glaucoma with a better success rate and greater IOP control compared to traditional trabeculotomy.
Read more: Illuminated microcatheter-assisted trabeculotomy effective for congenital glaucoma
- Details
The early advantage aflibercept showed in treating patients with DME narrowed after 2 years of treatment, according to follow-up data from the DRCR.net Protocol T study.
Read more: Ranibizumab catches up with aflibercept at 2 years
- Details
Patients participating in OpenNotes demonstrated better recall of their medical plans, felt more in control of their care and were more likely to take their medications.
Read more: Sharing notes with patients may enhance health outcomes